214 related articles for article (PubMed ID: 25965722)
1. The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study.
Hovingh GK; Smits LP; Stefanutti C; Soran H; Kwok S; de Graaf J; Gaudet D; Keyserling CH; Klepp H; Frick J; Paolini JF; Dasseux JL; Kastelein JJ; Stroes ES
Am Heart J; 2015 May; 169(5):736-742.e1. PubMed ID: 25965722
[TBL] [Abstract][Full Text] [Related]
2. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224
[TBL] [Abstract][Full Text] [Related]
3. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
4. Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.
Kootte RS; Smits LP; van der Valk FM; Dasseux JL; Keyserling CH; Barbaras R; Paolini JF; Santos RD; van Dijk TH; Dallinga-van Thie GM; Nederveen AJ; Mulder WM; Hovingh GK; Kastelein JP; Groen AK; Stroes E
J Lipid Res; 2015 Mar; 56(3):703-712. PubMed ID: 25561459
[TBL] [Abstract][Full Text] [Related]
5. Clinical observations and treatment of pediatric homozygous familial hypercholesterolemia due to a low-density lipoprotein receptor defect.
Huang CH; Chiu PC; Liu HC; Lu YH; Huang JK; Charng MJ; Niu DM
J Clin Lipidol; 2015; 9(2):234-40. PubMed ID: 25911080
[TBL] [Abstract][Full Text] [Related]
6. Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.
Nicholls SJ; Andrews J; Kastelein JJP; Merkely B; Nissen SE; Ray KK; Schwartz GG; Worthley SG; Keyserling C; Dasseux JL; Griffith L; Kim SW; Janssan A; Di Giovanni G; Pisaniello AD; Scherer DJ; Psaltis PJ; Butters J
JAMA Cardiol; 2018 Sep; 3(9):815-822. PubMed ID: 30046828
[TBL] [Abstract][Full Text] [Related]
7. Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia.
Santos RD; Raal FJ; Donovan JM; Cromwell WC
J Clin Lipidol; 2015; 9(2):201-9. PubMed ID: 25911076
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
Stein EA; Dufour R; Gagne C; Gaudet D; East C; Donovan JM; Chin W; Tribble DL; McGowan M
Circulation; 2012 Nov; 126(19):2283-92. PubMed ID: 23060426
[TBL] [Abstract][Full Text] [Related]
9. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
10. ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels.
Jun JE; Choi YJ; Lee YH; Kim DJ; Park SW; Huh BW; Lee EJ; Jee SH; Hur KY; Choi SH; Huh KB
Korean J Intern Med; 2018 Jan; 33(1):138-147. PubMed ID: 29334727
[TBL] [Abstract][Full Text] [Related]
11. Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.
van Tits LJ; van Himbergen TM; Lemmers HL; de Graaf J; Stalenhoef AF
Atherosclerosis; 2006 Apr; 185(2):307-12. PubMed ID: 16005883
[TBL] [Abstract][Full Text] [Related]
12. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia.
Ito MK; Watts GF
Drugs; 2015 Oct; 75(15):1715-24. PubMed ID: 26370207
[TBL] [Abstract][Full Text] [Related]
14. Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.
Wiegman A; Greber-Platzer S; Ali S; Reijman MD; Brinton EA; Charng MJ; Srinivasan S; Baker-Smith C; Baum S; Brothers JA; Hartz J; Moriarty PM; Mendell J; Bihorel S; Banerjee P; George RT; Hirshberg B; Pordy R
Circulation; 2024 Jan; 149(5):343-353. PubMed ID: 37860863
[TBL] [Abstract][Full Text] [Related]
15. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
[TBL] [Abstract][Full Text] [Related]
16. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
Vishwanath R; Hemphill LC
J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
[TBL] [Abstract][Full Text] [Related]
18. A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting.
Blom DJ; Gaudet D; Hegele RA; Patel DS; Cegla J; Kolovou G; Marin LM
Adv Ther; 2022 Apr; 39(4):1857-1870. PubMed ID: 35194765
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-23 in patients with homozygous familial hypercholesterolemia.
Zamparini JM; Immelman AR; Raal FJ
J Clin Lipidol; 2018; 12(3):767-772. PubMed ID: 29550495
[TBL] [Abstract][Full Text] [Related]
20. Acute myocardial infarction in an 8-year old male child with homozygous familiar hypercholesterolemia: laboratory findings and response to lipid-lowering drugs.
Wu NQ; Guo YL; Xu RX; Liu J; Zhu CG; Jiang LX; Li JJ
Clin Lab; 2013; 59(7-8):901-7. PubMed ID: 24133922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
